Diabetes 50:2133-2138, 2001
© 2001 by the American Diabetes Association, Inc.
Depressed Levels of Ca2+-Cycling Proteins May Underlie Sarcoplasmic Reticulum Dysfunction in the Diabetic Heart
Thomas Netticadan,
Rana M. Temsah,
Ardeep Kent,
Vijayan Elimban, and
Naranjan S. Dhalla
Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Winnipeg, Canada, and the Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada
In view of the depressed sarcoplasmic reticulum (SR) Ca2+-pump and Ca2+-release activities in the diabetic heart and the critical role of phosphorylation in regulating the SR function, we examined the status of Ca2+-calmodulindependent protein kinase (CaMK) and cAMP-dependent protein kinase (PKA)-mediated phosphorylations in the diabetic heart. Diabetes was induced in male Sprague-Dawley rats by an injection of streptozotocin (65 mg/kg i.v.), and the animals were killed 6 weeks later for assessment of the ventricular SR function. Depressed cardiac performance and SR Ca2+-uptake and -release activities in diabetic animals were accompanied by a significant decrease in the level of SR Ca2+-cycling proteins, such as ryanodine receptor, Ca2+-pump ATPase, and phospholamban. On the other hand, the CaMK- and PKA-mediated phosphorylations of these Ca2+-cycling proteins, the endogenous SR CaMK and PKA activities, and the endogenous SR and cytosolic phosphatase activities were increased in the diabetic heart. Treatment of 3-week diabetic animals with insulin partially or fully prevented the diabetes-induced changes in cardiac performance, SR Ca2+-uptake and -release activites, and SR protein content, whereas the diabetes-induced changes in SR CaMK- and PKA-mediated phosphorylations and activities, as well as phosphatase activities, were not significantly affected. These results suggest that the reduced content of the Ca2+-cycling proteins, unlike alterations in PKA and phosphatase activities, appear to be the major defect underlying SR dysfunction in the diabetic heart.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. K. Gerber, B. J. Aronow, and M. A. Matlib
Activation of a novel long-chain free fatty acid generation and export system in mitochondria of diabetic rat hearts
Am J Physiol Cell Physiol,
December 1, 2006;
291(6):
C1198 - C1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Vasanji, E. J. F. Cantor, D. Juric, M. Moyen, and T. Netticadan
Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance
Am J Physiol Cell Physiol,
October 1, 2006;
291(4):
C772 - C780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pereira, J. Matthes, I. Schuster, H. H. Valdivia, S. Herzig, S. Richard, and A. M. Gomez
Mechanisms of [Ca2+]i Transient Decrease in Cardiomyopathy of db/db Type 2 Diabetic Mice
Diabetes,
March 1, 2006;
55(3):
608 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Golfman, C. R. Wilson, S. Sharma, M. Burgmaier, M. E. Young, P. H. Guthrie, M. Van Arsdall, J. V. Adrogue, K. K. Brown, and H. Taegtmeyer
Activation of PPAR{gamma} enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats
Am J Physiol Endocrinol Metab,
August 1, 2005;
289(2):
E328 - E336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Minhas, S. A. Khan, S. V. Y. Raju, A. C. Phan, D. R. Gonzalez, M. W. Skaf, K. Lee, A. D. Tejani, A. P. Saliaris, L. A. Barouch, et al.
Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy
J. Physiol.,
June 1, 2005;
565(2):
463 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Montanari, H. Yin, E. Dobrzynski, J. Agata, H. Yoshida, J. Chao, and L. Chao
Kallikrein Gene Delivery Improves Serum Glucose and Lipid Profiles and Cardiac Function in Streptozotocin-Induced Diabetic Rats
Diabetes,
May 1, 2005;
54(5):
1573 - 1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Babick, E. J. F. Cantor, J. T. Babick, N. Takeda, N. S. Dhalla, and T. Netticadan
Cardiac contractile dysfunction in J2N-k cardiomyopathic hamsters is associated with impaired SR function and regulation
Am J Physiol Cell Physiol,
November 1, 2004;
287(5):
C1202 - C1208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, K. Wakabayashi, T. Kobayashi, and K. Kamata
Diabetes-related changes in cAMP-dependent protein kinase activity and decrease in relaxation response in rat mesenteric artery
Am J Physiol Heart Circ Physiol,
September 1, 2004;
287(3):
H1064 - H1071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Bidasee, Y. Zhang, C. H. Shao, M. Wang, K. P. Patel, U. D. Dincer, and H. R. Besch
Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase
Diabetes,
February 1, 2004;
53(2):
463 - 473.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Zhong, P. J Reiser, and M. A. Matlib
Gender differences in myosin heavy chain-{beta} and phosphorylated phospholamban in diabetic rat hearts
Am J Physiol Heart Circ Physiol,
December 1, 2003;
285(6):
H2688 - H2693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Bidasee, K. Nallani, Y. Yu, R. R. Cocklin, Y. Zhang, M. Wang, U. D. Dincer, and H. R. Besch Jr.
Chronic Diabetes Increases Advanced Glycation End Products on Cardiac Ryanodine Receptors/Calcium-Release Channels
Diabetes,
July 1, 2003;
52(7):
1825 - 1836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Bidasee, K. Nallani, H. R. Besch Jr., and U. D. Dincer
Streptozotocin-Induced Diabetes Increases Disulfide Bond Formation on Cardiac Ryanodine Receptor (RyR2)
J. Pharmacol. Exp. Ther.,
June 1, 2003;
305(3):
989 - 998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. L. Norby, L. E. Wold, J. Duan, K. K. Hintz, and J. Ren
IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes
Am J Physiol Endocrinol Metab,
October 1, 2002;
283(4):
E658 - E666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Young, P. H. Guthrie, P. Razeghi, B. Leighton, S. Abbasi, S. Patil, K. A. Youker, and H. Taegtmeyer
Impaired Long-Chain Fatty Acid Oxidation and Contractile Dysfunction in the Obese Zucker Rat Heart
Diabetes,
August 1, 2002;
51(8):
2587 - 2595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Razeghi, M. E. Young, T. C. Cockrill, O. H. Frazier, and H. Taegtmeyer
Downregulation of Myocardial Myocyte Enhancer Factor 2C and Myocyte Enhancer Factor 2C-Regulated Gene Expression in Diabetic Patients With Nonischemic Heart Failure
Circulation,
July 23, 2002;
106(4):
407 - 411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dimitropoulou, G. Han, A. W. Miller, M. Molero, L. C. Fuchs, R. E. White, and G. O. Carrier
Potassium (BKCa) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats
Am J Physiol Heart Circ Physiol,
March 1, 2002;
282(3):
H908 - H917.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|